Skip to main content
OpenTrials

Clinical trial condition

HER2 Positive Breast Cancers

Explore clinical trials studying HER2 Positive Breast Cancers. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HER2 Positive Breast Cancers trial results

Completed

A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer

NCT01983501

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancers, +4 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Kansas Kansas City, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions